RGC_OUT_1 [2025-04-28 11:46:14 -0400] 6497 Bytes | 1903 tokens | Cum: 1903 tkns (23.79% of 8k)
==========================================================================

Booyah, my friends! It's already 11:46 AM on Mon Apr 28, 2025, and I've got my eyes locked on Regencell Bioscience (RGC), pushing up to $35.97 from $29.01. Are we in for a serious bull run, or is this just hype? I've pulled the data—let's break it down!

--- COMPANY PROFILE ---
Company: Regencell Bioscience (RGC)
IPO: 2021-07-16 (3 Years Ago)
Market Cap: $377,242,985
Shares Outstanding: 13,010,000
Exchange: XNAS
Description: Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.

Here’s a list of headlines for Regencell Bioscience:

Mar-22-25 11:00AM - Investors To Focus On PCE Price Index Print As Cintas, Lululemon To Report Earnings
Mar-21-25 06:35AM - Why Regencell Bioscience Holdings Ltd. (RGC) Surged On Thursday?
Mar-17-25 07:28AM - Why Regencell Bioscience Holdings Limited (RGC) Soared Last Week?
Jul-23-24 04:02PM - What Is Going on With Regencell Bioscience (RGC) Stock Today?
Nov-15-23 04:31PM - 15 Developed Countries with Lowest Autism Rates
Jul-31-23 08:15AM - With 81% ownership, Regencell Bioscience Holdings Limited (NASDAQ:RGC) insiders have a lot riding on the company's future
Apr-03-23 07:25AM - One Regencell Bioscience Holdings Limited (NASDAQ:RGC) insider upped their stake by 0.5% in the previous year
Feb-21-23 06:36AM - With 81% ownership, Regencell Bioscience Holdings Limited (NASDAQ:RGC) insiders have a lot riding on the company's future
Nov-21-22 06:49AM - Companies Like Regencell Bioscience Holdings (NASDAQ:RGC) Are In A Position To Invest In Growth
Nov-15-22 07:55AM - RGC: Forging a New Approach to ADHD and ASD
Oct-25-22 06:55AM - One Regencell Bioscience Holdings Limited (NASDAQ:RGC) insider upped their stake by 1.4% in the previous year
Sep-14-22 06:55AM - 81% of Regencell Bioscience Holdings Limited (NASDAQ:RGC) is owned by insiders, and they've been buying recently
Sep-12-22 09:15AM - Regencell Biosciences Standardized Formulae Are Shown to Reduce ADHD and ASD Symptoms in the Interim Results of its Second Efficacy Trial
Jun-20-22 05:27AM - RGC: CEO Figuratively Putting His Money Where His Mouth Is
May-24-22 05:46AM - RGC: Second investigational study of RGC-COV19 replicates results of earlier trial in eliminating COVID-19 symptoms.
May-18-22 08:05AM - Regencell Bioscience Announces Additional EARTH Efficacy Trial Results Corroborating Effectiveness of its Investigational Liquid-Formula RGC-COV19TM in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-Day Treatment Period
May-18-22 08:05AM 06:14AM - The Founder of Regencell Bioscience Holdings Limited (NASDAQ:RGC), Yat-Gai Au, Just Bought A Few More Shares
May-16-22 08:56AM - Regencell Bioscience Holdings Limited Announces Over $5 Million Ordinary Share Purchases by CEO
Apr-14-22 10:03AM - RGC: Regencell Bioscience - Investigational Liquid-Formula RGC-COV19 Shows Promise in Eliminating COVID-19 Symptoms
Apr-07-22 06:09AM - What Is The Ownership Structure Like For Regencell Bioscience Holdings Limited (NASDAQ:RGC)?
Mar-01-22 08:30AM - Regencell Describes Their Traditional Chinese Medicine ("TCM") Treatments and Recent Efficacy Trial Results in New Video Interview on SNN Network
Feb-17-22 11:40AM - Regencell Bioscience's COVID-19 Candidate Shows Encouraging Action On Mild To Moderate Symptoms

Prior AI Reports for RGC:
1. 2025-04-04 – Score: 45 – Target: 30.7500 – Highs: 37.9996 / 35.4298 / 31.15
surging-performance-meets-financial-strain-a-closer-look-at-the-paradox-of-high-growth-amid-underlying-risks
2. 2025-03-31 – Score: 65 – Target: 51.5000 – Highs: 39.7760 / 33.8800 / 28.72
high-risk-high-growth-company-sparks-interest-amidst-uncertainty
3. 2025-03-24 – Score: 60 – Target: 88.0000 – Highs: 69.0000 / 49.0000 / 44.32
regencell-soars-amid-volatile-trading-and-financial-uncertainty
4. 2025-03-21 – Score: 65 – Target: 86.0400 – Highs: 64.7229 / 69.0000 / 49.00
regencells-stock-soars-amid-clouded-financial-health
5. 2025-03-20 – Score: 92 – Target: 60.0300 – Highs: 45.7300 / 64.7229 / 69.00
regencells-strong-momentum-signals-bullish-outlook

(Note: Highs = Same day / 2nd day / 3rd day)

Here's another list of headlines with menu handles.
I will deliver the full text of the following stories when you say their handle.
Just say, for example, B1, B2, etc.

B1 - 2024-07-24T09:27:11Z - Why Enphase Energy Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga
B2 - 2023-06-28T17:04:06Z - Why Eton Pharmaceuticals Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
B3 - 2023-06-05T17:09:08Z - Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
B4 - 2022-11-11T16:12:25Z - Flowers Foods, EverCommerce, And Some Other Big Stocks Moving Lower On Friday
B5 - 2022-09-23T16:16:12Z - Why Shares Of Oil & Gas Companies Are Trading Lower, Here Are 62 Stocks Moving In Friday's Mid-Day Session
B6 - 2022-09-23T14:30:36Z - Domino's Pizza, Athersys And Some Other Big Stocks Moving Higher On Friday

==============
-> THE ROLE FOR AI:
==============

1) You are the **AI analyst-investigator**, and this interaction represents a full **due diligence session** for Regencell Bioscience (RGC).
Due diligence includes financial data, insider trading, relevant news, and any SEC filings — and may extend beyond classic fundamentals.
Your task is to identify whether this stock has momentum and potential.

2) I am **ScanScor**, a unified report generator that archives this session as part of our real-time diligence record.

3) You will request information by referencing documents by their code.

4) As the analysis proceeds, your are encouraged to review documents until you feel confident in your judgment.
After seeing 3 sets of news articles, SEC docs, and financials, you'll be prompted to return some data pairs.

5) News articles, SEC filings, and key metrics will be revealed in subsequent prompts.

Stay focused. Gather evidence. Continue until your conclusions are clear.
Restrict all your responses to just 3 tokens until the summary and data pairs at the end.

NEXT: Request a document with its reference code(s), such as:
- `B1`, `B2`, `B3`, etc.
- To load a new set of information and menu options, reply with: `NEX`

RGC_OUT_3 [2025-04-28 11:46:15 -0400] 1039 Bytes | 310 tokens | Cum: 2215 tkns (27.69% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-04-11T17:06:11Z - 12 Health Care Stocks Moving In Friday's Intraday Session - CeriBell (NASDAQ:CBLL), CEL-SCI (AMEX:CV...
A2 - 2025-04-11T14:40:09Z - Fastenal Posts Better-Than-Expected Sales, Joins Simulations Plus, Certara And Other Big Stocks Movi...
A3 - 2025-04-04T17:06:22Z - 12 Health Care Stocks Moving In Friday's Intraday Session - Aldeyra Therapeutics (NASDAQ:ALDX), Adap...
A4 - 2025-04-04T14:05:19Z - Simulations Plus Posts Better-Than-Expected Results, Joins Savers Value Village, MarketAxess Holding...
A5 - 2025-04-02T11:32:27Z - nCino Posts Weak Earnings, Joins Tesla And Other Big Stocks Moving Lower In Wednesday's Pre-Market S...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

RGC_OUT_5 [2025-04-28 11:46:16 -0400] 1181 Bytes | 373 tokens | Cum: 2590 tkns (32.38% of 8k)
==========================================================================

Showing A1 (chunk 1 of 3): A1:
**12 Health Care Stocks Moving In Friday's Intraday Session - CeriBell (NASDAQ:CBLL), CEL-SCI (AMEX:CVM)**Date: 2025-04-11Source: {'uri': 'benzinga.com', 'dataType': 'news', 'title': 'Benzinga'}URL: https://www.benzinga.com/insights/movers/25/04/44769092/12-health-care-stocks-moving-in-fridays-intraday-sessionGainers Portage Biotech PRTG shares rose 86.6% to $9.52 during Friday's regular session. The market value of their outstanding shares is at $15.6 million. MSP Recovery MSPR stock moved upwards by 85.15% to $2.37. The company's market cap stands at $5.0 million. CeriBell CBLL shares rose 35.78% to $15.14. The company's market cap stands at $543.0 million. Regencell Bioscience RGC shares increased by 35.02% to $38.13. The company's market cap stands at $496.1 million. Sharps Technology STSS shares moved upwards by 34.42% to $0.02. CEL-SCI CVM shares rose 27.88% to $0.27. The compa

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

RGC_OUT_7 [2025-04-28 11:46:17 -0400] 1181 Bytes | 338 tokens | Cum: 2930 tkns (36.62% of 8k)
==========================================================================

Showing A1 (chunk 2 of 3): ny's market cap stands at $22.6 million. Losers Innovative Eyewear LUCY stock fell 53.3% to $2.31 during Friday's regular session. The company's market cap stands at $5.6 million. Palatin Techs PTN stock declined by 44.04% to $0.24. The market value of their outstanding shares is at $6.1 million. Wellgistics Health WGRX shares declined by 29.45% to $2.76. The market value of their outstanding shares is at $143.2 million. Organovo Holdings ONVO stock fell 22.96% to $1.68. The market value of their outstanding shares is at $3.0 million. cbdMD YCBD stock declined by 21.52% to $0.22. The company's market cap stands at $1.3 million. Reshape Lifesciences RSLS shares declined by 15.96% to $0.48. The market value of their outstanding shares is at $5.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

RGC_OUT_9 [2025-04-28 11:46:18 -0400] 971 Bytes | 335 tokens | Cum: 3267 tkns (40.84% of 8k)
==========================================================================

Showing A1 (chunk 3 of 3): by an editor.

CBLLCeriBell Inc$15.1335.6%Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock - anytime.

Reveal Full ScoreEdge RankingsMomentum-Growth-Quality-Value65.62Price TrendShortMediumLongOverviewCVMCEL-SCI Corp$0.261924.2%LUCYInnovative Eyewear Inc$2.25-54.5%MSPRMSP Recovery Inc$2.4187.9%ONVOOrganovo Holdings Inc$1.68-22.9%PRTGPortage Biotech Inc$10.14101.2%PTNPalatin Technologies Inc$0.2349-44.4%RGCRegencell Bioscience Holdings Ltd$37.8033.9%RSLSReshape Lifesciences Inc$0.4782-15.6%STSSSharps Technology Inc$0.024131.7%WGRXWellgistics Health Inc$2.77-29.3%YCBDcbdMD Inc$0.2178-21.6%Market News and Data brought to you by Benzinga APIs

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

RGC_OUT_11 [2025-04-28 11:46:19 -0400] 238 Bytes | 59 tokens | Cum: 3328 tkns (41.60% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

RGC_OUT_13 [2025-04-28 11:46:20 -0400] 251 Bytes | 78 tokens | Cum: 3409 tkns (42.61% of 8k)
==========================================================================

You just read a chunk of S1.
You may now:
- Say "MOR" to continue this article
- Say "S2", "S3", etc. to request another
- Or say "NEX" to move to the next source

You are allowed up to 6 articles from this list. If you’re ready to move on, say NEX.

RGC_OUT_15 [2025-04-28 11:46:29 -0400] 5922 Bytes | 1604 tokens | Cum: 5016 tkns (62.70% of 8k)
==========================================================================

This is our set of metrics for Regencell Bioscience.
Please analyze the numbers.

+---------------------+-----------------------+------------------------+-------------------+
| Volume: 136,149 | Perf Month: 2.61% | Option/Short: No / Yes | Sales Y/Y TTM: - |
+---------------------+-----------------------+------------------------+-------------------+
| Avg Volume: 665.78K | Perf Quarter: 772.68% | Short Float: 2.17% | ROE: -42.49% |
+---------------------+-----------------------+------------------------+-------------------+
| Rel Volume: 0.60 | Index: - | Short Ratio: 0.03 | ROI: -52.18% |
+---------------------+-----------------------+------------------------+-------------------+
| RSI (14): 59.14 | Market Cap: 465.60M | Short Interest: 0.02M | Sales Surprise: - |
+---------------------+-----------------------+------------------------+-------------------+
| ATR (14): 6.05 | Shs Outstand: 13.01M | Beta: -4.22 | EPS Surprise: - |
+---------------------+-----------------------+------------------------+-------------------+
| SMA20: 20.05% | Shs Float: 0.80M | Sales Q/Q: - | P/E: - |
+---------------------+-----------------------+------------------------+-------------------+
| SMA50: 67.70% | Inst Own: 0.24% | Sales past 5Y: 0.00% | Earnings: - |
+---------------------+-----------------------+------------------------+-------------------+
| SMA200: 260.53% | Insider Own: 93.84% | Employees: 12 | |
+---------------------+-----------------------+------------------------+-------------------+
| Perf Week: 23.38% | Insider Trans: 0.00% | Debt/Eq: 0.01 | |
+---------------------+-----------------------+------------------------+-------------------+

The next section covers any insider trading by Regencell Bioscience officers or majority shareholders (if available).

[Company Financial Summary]
[Company Details]
Name: N/A
Market Cap: N/A
Shares Outstanding: N/A
Sector: N/A

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): {'value': 3163000000.0, 'unit': 'USD', 'label': 'Revenues', 'order': 100}
Net Income: {'value': 112300000.0, 'unit': 'USD', 'label': 'Net Income/Loss', 'order': 3200}
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 35.0969
Average Volume: 91854.5
30-Day High: 36.28
30-Day Low: 23.53

[Detailed Financials: TTM 2017]
- Total Assets: $2,842,900,000.00
- Total Liabilities: $3,698,700,000.00
- Total Equity: $-855,800,000.00
- Current Assets: $463,300,000.00
- Current Liabilities: $561,400,000.00

[Income Statement: TTM 2017]
- Revenue: $3,163,000,000.00
- Net Income: $112,300,000.00
- Gross Profit: N/A
- Operating Income: $271,700,000.00
- Earnings Per Share (EPS): 0.72

[Cash Flow Statement: TTM 2017]
- Net Cash Flow: $-17,700,000.00

[Detailed Financials: FY 2017]
- Total Assets: $2,842,900,000.00
- Total Liabilities: $3,698,700,000.00
- Total Equity: $-855,800,000.00
- Current Assets: $463,300,000.00
- Current Liabilities: $561,400,000.00

[Income Statement: FY 2017]
- Revenue: $3,163,000,000.00
- Net Income: $112,300,000.00
- Gross Profit: N/A
- Operating Income: $271,700,000.00
- Earnings Per Share (EPS): 0.72

[Cash Flow Statement: FY 2017]
- Net Cash Flow: $-17,700,000.00
==== END OF FINANCIAL REPORT ====

You are now requested to write a summary analysis of Regencell Bioscience (RGC).

Please complete the report using the exact format:
FIELD[value]

1) BRIEF_SUMMARY[]
One well-worded paragraph summarizing your findings about Regencell Bioscience.

2) MARKET_SCORE[]
This conversation was initiated because RGC is currently experiencing upward price and volume movement.
Estimate a number between 1–100 based on the likelihood of a continued upward price move for RGC.
Weigh relevant data — news, filings, fundamentals, and metrics — and assign appropriate weight.

3) PRICE_TARGET[]
Suggest a price, based on all prior evidence and past price behavior, RGC could reach in the current or upcoming trading sessions (1–5 days).
For example, if you expect RGC to increase 50% from its current price of $0.00, say: PRICE_TARGET[0.0]

4) AI_RPT_HEADLINE[]
Write a thought-provoking 8–12 word headline summarizing this report.

5) SQUEEZE_POTENTIAL[]
Give a score from 1 to 100 representing the potential for this stock to become an active short squeeze play.
Be honest and unbiased. Consider short interest/float, price movement, volume, news strength, and volatility potential.

6) TAGS[]
List 3–6 comma-separated tags (e.g., biotech, earnings beat, squeeze setup)

7) STOCK_TYPE[]
Choose the most accurate classification: growth, value, turnaround, hype, squeeze, dividend, speculative, or other.

8) PRIMARY_CATALYST[]
e.g., earnings report, FDA approval, partnership, etc.

9) SENTIMENT[]
bullish, bearish, neutral, or mixed

10) IMPROVEMENT_SUGGESTION[]
If you believe some key info was missing, state what would have significantly improved your analysis of Regencell Bioscience.

11) ETHICAL_RATING[]
Rate Regencell Bioscience’s alignment with long-term shareholder interests, using a letter grade from A (high alignment) to F (low alignment).
Base this on actions such as insider buying/selling, share dilution, follow-through on public statements, and compensation practices.

12) UPCOMING_CATALYST[]
Specify any upcoming events you expect would be a catalyst affecting the share-price of Regencell Bioscience.
Provide any reasons you can use to support it.

Return only: FIELD[value] for each of the above 12 questions.
Respond with all data pairs. Take your best guess if you have to, but don't leave blank items.
Do not explain your answers. Return only the required fields in the exact format shown.

Finally, thank you for participating!

RGC_IN_17 [2025-04-28 11:46:29 -0400] 126 Bytes | 29 tokens | Cum: 5329 tkns (66.61% of 8k)
==========================================================================

====================================
[2025-04-28 11:46:29] # Analysis Completed
Elapsed Time: 16.53 seconds